Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
New investors in 2023 must understand the current market landscape. Familiarize yourself with essential tips and strategies to thrive in investing.
28,353 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Planners say the key to retirement security lies in inflation adjusted dividend income, built from steady dividend gr...
Target stock has captured attention as it tries to outpace rivals like Amazon, Walmart, and Costco. This guide breaks...
Three monthly dividend ETFs are drawing attention for steady payouts and yields that beat Treasuries. This piece brea...
A lone IBIT block trade worth about $1.26 billion crossed the tape at $43.16 per share, yet the ETF barely budged. Bi...
The June jobs report shows tepid hiring even as unemployment falls, highlighting mixed signals for households and mar...
Walmart raises its payout to 0.99 per share, extending a 53-year dividend-raising streak and keeping Dividend King st...
A rare ‘super’ niño looking could intensify weather extremes this year, impacting crops, energy costs, and budgets. H...
Synopsys rides AI-driven demand in EDA and IP, delivering solid quarterly results and a robust backlog as the AI buil...
Two widely watched real estate ETFs take different paths to property exposure. This gqre icf: matchup real guide comp...
NVIDIA leads the AI chip market with strong cash returns, while Intel pursues a turnaround with a cautious growth pro...
U.S. stocks pulled back after signals that a ceasefire may be unraveling, lifting oil and turning traders toward safe...